Clinical Trials Logo

Clinical Trial Summary

This trial is a multi-center phase III clinical trial. The purpose of this trial is to explore whether 2 cycles induction chemotherapy combined with concurrent chemoradiotherapy is not inferior to 3 cycles induction chemotherapy combined with concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05860868
Study type Interventional
Source First Affiliated Hospital, Sun Yat-Sen University
Contact Cheng-Tao Wang
Phone +862087755766
Email wangcht5@mail.sysu.edu.cn
Status Recruiting
Phase Phase 3
Start date May 2023
Completion date May 2030

See also
  Status Clinical Trial Phase
Recruiting NCT05062005 - ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma Phase 3
Completed NCT01462474 - Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma Phase 1
Recruiting NCT03574324 - TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC Phase 3
Recruiting NCT05397769 - Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial. Phase 2
Not yet recruiting NCT04910347 - A Phase 2, Open-label Trial of Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma Phase 2
Not yet recruiting NCT05892354 - Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy N/A
Recruiting NCT03604965 - GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC Phase 3
Recruiting NCT03015727 - Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma Phase 3
Recruiting NCT05503914 - Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma N/A